Type of Material: | Thesis |
Title: | Liposome formulation of anticancer drug and its pharmacokinetics and toxicokinetic evaluation |
Researcher: | Shetty, Raghavendra |
Guide: | Kumar, Vimal |
Department: | Institute of Pharmacy |
Publisher: | Nirma University |
Place: | Ahmedabad |
Year: | 2010 |
Language: | English |
Subject: | Pharmacy | Liposome | Pharmacokinetics | Toxicokinetic | Anticancer drug |
Dissertation/Thesis Note: | PhD |
Fulltext: | Shodhganga |
000 | 00000ntm a2200000ua 4500 | |
001 | 261724 | |
003 | IN-AhILN | |
005 | 2013-12-05 06:18:49 | |
008 | __ | 110823t2010||||ii#||||g|m||||||||||eng|| |
035 | __ | |a(IN-AhILN)th_261724 |
040 | __ | |aNIRU_382481|dIN-AhILN |
041 | __ | |aeng |
100 | __ | |aShetty, Raghavendra|eResearcher |
110 | __ | |aInstitute of Pharmacy|bNirma University|dAhmedabad |
245 | __ | |aLiposome formulation of anticancer drug and its pharmacokinetics and toxicokinetic evaluation |
260 | __ | |aAhmedabad|bNirma University|c2010 |
502 | __ | |bPhD |
518 | __ | |oDate of Notification|d2010 |
520 | __ | |aThe aim of the present study was to design a controlled delivery system of Irinotecan using PEGylated liposomes to overcome the limitations of conventional i.v. formulation therapy and to investigate its in vivo performance for sustained delivery and po |
653 | __ | |aPharmacy |
653 | __ | |aLiposome |
653 | __ | |aPharmacokinetics |
653 | __ | |aToxicokinetic |
653 | __ | |aAnticancer drug |
700 | __ | |aKumar, Vimal|eGuide |
856 | __ | |uhttp://shodhganga.inflibnet.ac.in/handle/10603/2315|yShodhganga |
905 | __ | |anotification |
User Feedback Comes Under This section.